Breaking News

Dr. Reddy's of Interim Phase-3 data> The efficacy against #COVID19 was reported at 91.6%

02 February ,

Dr. Reddy's is pleased to share that #SputnikV showed strong efficacy, immunogenicity, & safety results in the Interim Phase-3 data on 19866 people in the trials conducted by its partner, RDIF. The efficacy against #COVID19 was reported at 91.6%

No comments

Subscribe to: Post Comments ( Atom )